Safety and Efficacy of Autologous RNA Chimeric Antigen Receptor T-cell (rCAR-T) Therapy in Myasthenia Gravis: a prospective, multicenter, open-label, non-randomised phase 1b/2a study

Saved in:

Bibliographic Details
Published in	Lancet neurology Vol. 22; no. 7; pp. 578 - 590
Main Authors	Granit, Volkan, Benatar, Michael, Kurtoglu, Metin, Miljković, Miloš D., Chahin, Nizar, Sahagian, Gregory, Feinberg, Marc H., Slansky, Adam, Vu, Tuan, Jewell, Christopher M., Singer, Michael S., Kalayoglu, Murat V., Howard, James F., Mozaffar, Tahseen
Format	Journal Article
Language	English
Published	01.07.2023
Online Access	Get full text

Loading…

More Information
Bibliography:	Both first authors contributed to the work equally. All authors had full access to the study design information and all data in the study, reviewed, edited, and provided final approval of the manuscript content, and had final responsibility for the decision to submit for publication. Study design: VG, MB, MK, MSS, MVK, TM. Investigation and data collection: VG, NC, GS, MHF, AS, TV, JFH, TM. Data analysis: MDM. Data verification: MK, JFH. Data interpretation: VG, MB, CJ, MSS, JFH, TM. Writing — original draft: VG, MDM. Both senior authors contributed to the work equally. Contributors statement
ISSN:	1474-4422 1474-4465
DOI:	10.1016/S1474-4422(23)00194-1